Medicines, 2020
Shortlist up to four to read them side by side.
1,035 medicine recalls FDA’s Enforcement Report published in 2020, newest first; 18,075 in all since 2012.
FDA’s medicine recalls, as its Enforcement Report classifies them, from June 2012. Lists of FDA’s records can’t be saved for alerts: openFDA asks that its data not be used to alert the public (openFDA); FDA’s own emails do that. Copied Nov 6, 2026.
1,035of 1,035 medicine recallsshown with your filters
The list
- Medicine recall HYDROMORPHONE 20MG/ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall HYDROMORPHONE 2MG/ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall HYDROMORPHONE 3MG/ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall HYDROMORPHONE 4MG/ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall HYDROMORPHONE 5MG/ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall HYDROMORPHONE 6MG/ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall IPAMORELIN 2000MCG/ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall LIPO B 25MG/50MG/50MG/1000MCG/ML Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall MORP 20MG/SUF 70MCG/ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall MORPHINE 10MG/ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall MORPHINE 15MG/ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall MORPHINE 18MG/ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall MORPHINE 1MG/ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall MORPHINE 20MG/ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall MORPHINE 2MG/ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall MORPHINE 30MG/ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall MORPHINE 4MG/ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall MORPHINE 5MG/ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall MORPHINE 6MG/ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall MORPHINE 7MG/ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall PHENOL 2.5% STERILE SOLUTION Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall QUADMIX in 1 mL vial Assurance Infusion (713)-533-8800 Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall QUADMIX 30MG/2MG/20MCG/100MCG/ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall QUADMIX FORTE Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall QUADMIX FORTE 30MG/4MG/40MCG/400MCG/ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall SUFENTANIL 150MCG/ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall SUFENTANIL 300MCG/ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall SUFENTANIL 55.5 MCG/ML Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall TESTOSTERONE CYP 200MG/ML OIL Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall TESTOSTERONE CYP 200MG/ML OIL (SESAME) INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall TESTOSTERONE CYP 200MG/ML OIL INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall TRIMIX 30MG/1MG/10MCG/ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall TRIMIX (UA) 30MG/1MG/20MCG/ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall TRIMIX -A (UA) 30MG/1MG/5 MCG/ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall TRIMIX FORTE 30MG/2MG/20MCG/ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall TRIMIX FORTE 4 (UA) 30MG/3MG/30MCG/ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall TRIMIX FORTE PLUS 30MG/4MG/40MCG/ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall TRIMIX SUPER (A) 30MG/2MG/30MCG/ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Estriol USP Micronized a) 100 gm Subpotent Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNot namedno state, in where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNo state named
- Medicine recall Yeast Arrest, Homeopathic Formula, Vaginal Support suppositories cGMP violations Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportOregonthe one state its words name PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereOregon
- Medicine recall Eczema Skin Relief Lotion, 2% Colloidal Oatmeal Skin Protectant Lotion Microbial contamination of non-sterile product. Class IIIFDA’s classJan 22, 2020in FDA’s Enforcement ReportIllinoisthe one state its words name PublishedJan 22, 2020ClassClass IIIStatusTerminatedWhereIllinois
- Medicine recall Testosterone Cypionate for Injection, USP, 1,000 mg/10 mL cGMP Deviations; released lots were manufactured under similar manufacturing conditions to a previously rejected OOS Lot. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Testosterone Cypionate for Injection, 2,000 mg/10 mL cGMP Deviations; released lots were manufactured under similar manufacturing conditions to a previously rejected OOS Lot. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Moxifloxacin Ophthalmic Solution USP, 0.5%, Sterile, 3mL Bottle Discoloration: Market complaints of discoloration in Moxifloxacin Ophthalmic Solution. Class IIIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall Tri-Lo-Marzia (Norgestimate and Ethinyl Estradiol Tablets, USP), 0.180 mg/0.025 mg CGMP Deviations: Out of specification test result observed during retrospective review of blend uniformity test data. Class IIIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall Lipoic Acid Injection (aka Alpha Lipoic Acid or Thioctic Acid), 1,200 mg/30 mL Presence of Particulate Matter: filmy/cloudy particulate observed in vial. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Ketorolac Tromethamine Injection, USP 30 mg/mL Presence of Particulate Matter: particles identified as polydimethylsiloxane (PDMS) FDA Class I, its most serious class Class IFDA’s class (needs attention)Jan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IStatusTerminatedWhereNationwide
- Medicine recall Blisovi Fe 1.5/30 (norethindrone acetate and ethinyl estradiol tablets USP and ferrous fumarate tablets 75mg) Failed Tablet/Capsule Specifications: Complaints related to crumbling of tablets when popped out of the blister pack. Class IIFDA’s classJan 15, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 15, 2020ClassClass IIStatusTerminatedWhereNationwide
Nothing matches all of these.
Remove a filter to see more. Each one is a fact FDA’s record publishes, so a recall can be left out because its record is silent on it.
FDA, Drug recall enforcement reports. Released Nov 3, 2026. Updated weekly.
Recalls of food, medicines, medical devices, pet food and animal drugs are from the U.S. Food and Drug Administration (FDA). FDA does not endorse Hearth Record. openFDA: “Do not rely on openFDA to make decisions regarding medical care.”
Your shortlist0 of 4
Add one more to compare.